This leads to the release of TAAs in a T cell inflamed TME capable of recruiting and activating antigen presenting cells (APCs), such as dendritic cells (DC) and anti-tumor CD8+ T cells (14, 18, 20, 21). Here, CD8A is linked to neoplasm.